Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection.

Abstract

Ribavirin was approved in early 1986 for treatment of illness associated with respiratory syncytial virus (RSV) infection in hospitalized children; however, the value of its use remains controversial. This investigation was undertaken to describe ribavirin utilization and to evaluate the effectiveness of ribavirin in reducing the period of hospitalization… (More)

Topics

  • Presentations referencing similar topics